Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 深圳市尚荣医疗股份有限公司(以下简称“公司”、或“尚荣医疗”)创立于1998年并于2011年2月在深圳证券交易所主板上市。自成立以来,公司一直秉承“以德为尚,以质为荣”的经营理念。从业20余年,公司已为数千家医院提供了现代化医院建设整体解决方案,积累了丰富的行业经验、专业人才、核心技术、应用软件以及最优的行业解决方案。尚荣医疗作为中国医院建设及医疗专业工程行业的领先者,开创了国内医院建设整体解决方案及医疗系统集成一站式服务的先河。 公司是国内最早将洁净技术引入医院手术部的企业之一,公司的智能自控手术室产品荣获国家科技部、商务部、质量监督总局及环保总局颁发的国家重点新产品荣誉,荣获深圳市人民政府颁发的科学技术进步二等奖,荣获深圳市科技和信息局颁发的高新技术项目。公司是国家级高新技术企业、深圳市自主创新行业领军企业之一、深圳市高新技术企业、深圳市知识产权优势企业。 公司主营业务为提供现代化医院建设整体解决方案,具体包括医疗产品,医疗服务和产业整合三大业务板块。 公司依托医院整体建设业务为客户提供医院整体规划设计,医院建筑工程的管理实施、医疗专业工程的专业设计与安装和医疗器械的配置等服务的优势,运用并购投资手段,构建起覆盖医院规划设计、医院建设、医疗专业工程、医用软件开发、医疗设备销售、医用耗材销售、医院后勤托管、医院建设及投资全产业链条。 通过各个环节的协同效应的,使公司具有产业链核心优势,在激烈的市场竞争中处于领先地位。 | ||||||||||||||||||||||||
Main Business | 医疗产品生产销售、医疗服务和健康产业 | ||||||||||||||||||||||||
Legal Representative | 梁桂秋 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 林立 | ||||||||||||||||||||||||
Solicitors | 广东华商律师事务所 | ||||||||||||||||||||||||
Auditors | 大华会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0755-89322101 | ||||||||||||||||||||||||
Fax No | 0755-89926159 | ||||||||||||||||||||||||
Website | www.glory-medical.com.cn | ||||||||||||||||||||||||
gen@glory-medical.com.cn | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 25/02/2011 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ -0.176 | ||||||||||||||||||||||||
DPS(RMB)* | -- | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 3.090 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 1.721B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |